Literature DB >> 21716106

Management of severe acute asthma in the emergency department.

Brian H Rowe1, William Sevcik, Cristina Villa-Roel.   

Abstract

PURPOSE OF REVIEW: Asthma is one of the most common chronic diseases in most developed countries and control may be elusive. Deterioration in asthma control is common when patients are exposed to airway irritants, viruses, and/or when adherence to chronic anti-inflammatory medications is suboptimal. Acute asthma exacerbations are common, important reasons for presentations to emergency departments, and severe cases may result in hospitalization. Important knowledge gaps exist in what is known and what care is delivered at the bedside. RECENT
FINDINGS: The literature in asthma is rapidly expanding and recent advances in the care are important to summarize. Systematic reviews, especially high-quality syntheses performed using Cochrane methods, provide the best evidence for busy clinicians to remain current. Management of asthma is based on early recognition of severe disease with aggressive therapy using multimodal interventions that focus on both bronchoconstriction and inflammatory mechanisms.
SUMMARY: Treatment of severe acute asthma can effectively and safely reduce hospitalizations, airway interventions, and even death. Using the approach outlined herein will enable clinicians to assist patients to rapidly regain asthma control, return to normal activities, and improve their quality of life in the follow-up period.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716106     DOI: 10.1097/MCC.0b013e328348bf09

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  6 in total

1.  Our paper 20 years later: the unfulfilled promises of nebulised adrenaline in acute severe asthma.

Authors:  Fekri Abroug; Fahmi Dachraoui; Lamia Ouanes-Besbes
Journal:  Intensive Care Med       Date:  2016-01-29       Impact factor: 17.440

2.  The Relationship between Hypomagnesemia and Pulmonary Function Tests in Patients with Chronic Asthma.

Authors:  Hatice Kılıc; Asiye Kanbay; Ayşegul Karalezlı; Elif Babaoglu; H Canan Hasanoglu; Ozcan Erel; Can Ates
Journal:  Med Princ Pract       Date:  2018-02-18       Impact factor: 1.927

3.  Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma.

Authors:  Tamer Y El Mays; Parichita Choudhury; Richard Leigh; Emmanuel Koumoundouros; Joanne Van der Velden; Grishma Shrestha; Cora A Pieron; John H Dennis; Francis Hy Green; Ken J Snibson
Journal:  Respir Res       Date:  2014-09-16

4.  A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.

Authors:  Veronica Swystun; Francis H Y Green; John H Dennis; Emmanouil Rampakakis; Gurkeet Lalli; Morenike Fadayomi; Andrea Chiu; Grishma Shrestha; Sharif Galal El Shahat; David Evan Nelson; Tamer Y El Mays; Cora A Pieron; Richard Leigh
Journal:  Trials       Date:  2018-06-18       Impact factor: 2.279

5.  Quality of Life in Children with Asthma versus Healthy Children.

Authors:  Samaneh Kouzegaran; Parisa Samimi; Hamid Ahanchian; Maryam Khoshkhui; Fatemeh Behmanesh
Journal:  Open Access Maced J Med Sci       Date:  2018-08-16

6.  A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers.

Authors:  Francis H Y Green; Richard Leigh; Morenike Fadayomi; Gurkeet Lalli; Andrea Chiu; Grishma Shrestha; Sharif G ElShahat; David Evan Nelson; Tamer Y El Mays; Cora A Pieron; John H Dennis
Journal:  Trials       Date:  2016-07-28       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.